Patent details
EP4110335 Title: IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT
Basic Information
- Publication number:
- EP4110335
- PCT Application Number:
- US2021019376
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217123777
- PCT Publication Number:
- WO2021173641
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT
- French Title of Invention:
- TRAITEMENT AMÉLIORÉ DE DERMATITE ATOPIQUE AU MOYEN DE TRADIPITANT
- German Title of Invention:
- VERBESSERTE BEHANDLUNG VON ATOPISCHER DERMATITIS MIT TRADIPITANT
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 27/10/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 31/10/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 15/10/2025
- Unitary Effect Registration Date:
- 31/10/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 24/02/2021
- Grant date:
- 15/10/2025
- EP Publication Date:
- 04/01/2023
- PCT Publication Date:
- 02/09/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/10/2025
- EP B1 Publication Date:
- 15/10/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 24/02/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/10/2025
- Name:
- Vanda Pharmaceuticals Inc.
- Address:
- 2200 Pennsylvania Ave NW Suite 300E, Washington, DC 20037, United States (US)
Inventor
1
- Name:
- POLYMEROPOULOS, Mihael, H.
- Address:
- United States (US)
2
- Name:
- POLYMEROPOULOS, Christos
- Address:
- United States (US)
3
- Name:
- BIRZNIEKS, Gunther
- Address:
- United States (US)
Priority
- Priority Number:
- 202062981481 P
- Priority Date:
- 25/02/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/444; A61K 31/4035; A61K 31/438; A61K 31/439; A61K 31/454; A61K 31/495; A61K 31/496; A61K 31/675; A61P 17/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202542
- Publication date:
- 15/10/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202549
- Publication date:
- 03/12/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202549
- Publication date:
- 03/12/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|